April 2023

TELA Bio

TELA Bio

Financial Advisor (Follow-On)

Canaccord Genuity Acted as Financial Advisor to TELA Bio on its US$45,125,000 Follow-On Offering

More Like This

C$3.3b

Pending Completion

dentalcorp

Financial Advisor to dentalcorp Holdings on its Sale to GTCR
US$29m

September 2025

Lucid Diagnostics

Joint Bookrunner (Follow-On Offering)
US$637m

September 2025

Vitruvian Partners

Advisor to Vitruvian Partners on its $637 Million Investment in DeepIntent

View all Healthcare transactions